HomeCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Nakaraang pagsara
$148.87
Sakop ng araw
$149.03 - $154.01
Sakop ng taon
$91.86 - $230.02
Market cap
7.49B USD
Average na Volume
880.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.03B | 0.59% |
Gastos sa pagpapatakbo | 211.51M | 8.67% |
Net na kita | 52.33M | -44.38% |
Net profit margin | 5.07 | -44.71% |
Kita sa bawat share | 3.12 | 11.43% |
EBITDA | 327.04M | 26.18% |
Aktuwal na % ng binabayarang buwis | 26.22% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 182.82M | 2.01% |
Kabuuang asset | 7.56B | -4.88% |
Kabuuang sagutin | 4.16B | -0.34% |
Kabuuang equity | 3.40B | — |
Natitirang share | 49.21M | — |
Presyo para makapag-book | 2.18 | — |
Return on assets | 5.68% | — |
Return on capital | 6.93% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 52.33M | -44.38% |
Cash mula sa mga operasyon | 204.60M | 5.72% |
Cash mula sa pag-invest | -37.34M | 39.65% |
Cash mula sa financing | -226.92M | 20.62% |
Net change in cash | -46.99M | 70.17% |
Malayang cash flow | 228.38M | 54.82% |
Tungkol
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in preclinical and clinical laboratory, gene therapy and cell therapy services and supplies for the pharmaceutical, medical device and biotechnology industries.
The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories frequently criticized by animal rights activists, who condemn the company's use of dogs and primates for pharmaceutical research. The company is also a major harvester of blood from horseshoe crabs. Wikipedia
Itinatag
1947
Headquarters
Website
Mga Empleyado
19,400
